2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Metoprolol and paroxetine/fluoxetine are inevitably co-prescribed because cardiovascular disorders and depression often coexist in the elderly. This leads to CYP2D6-mediated drug-drug interactions (DDI). Because systematic evaluations are lacking, we assessed the burden of metoprolol-paroxetine/fluoxetine interaction in the elderly and how these interactions are managed in Dutch community pharmacies.

          Related collections

          Author and article information

          Journal
          Pharmacoepidemiol Drug Saf
          Pharmacoepidemiology and drug safety
          Wiley
          1099-1557
          1053-8569
          Jul 2017
          : 26
          : 7
          Affiliations
          [1 ] University of Groningen, Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen, The Netherlands.
          [2 ] Hasanuddin University, Faculty of Pharmacy, Makassar, Indonesia.
          [3 ] Health Base Foundation, Department of Clinical Decision Support, Houten, The Netherlands.
          [4 ] University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
          Article
          10.1002/pds.4200
          28345306
          ba05348c-56eb-4171-ab5d-ec1c5b463d95
          History

          CYP2D6,beta-blockers,cytochrome P450 (CYP)-based drug-drug interactions (DDI),metoprolol,paroxetine/fluoxetine,pharmacoepidemiology,antidepressants

          Comments

          Comment on this article